An early discharge strategy with rivaroxaban reduces hospital lengths of stay and healthcare costs for patients with low-risk pulmonary embolism (LRPE)—without compromising their safety—suggests a study published in Academic Emergency Medicine.

The 200 and 250 millimeter lengths of Medtronic’s IN.PACT Admiral drug-coated balloon gained FDA approval to treat long superficial artery (SFA) lesions in patients with peripheral artery disease (PAD), the company announced June 15.

New research suggests flavorings in electronic cigarettes, or e-cigarettes—including mint, vanilla, cinnamon and strawberry—can adversely affect endothelial cells, according to a study published June 14 in Arteriosclerosis, Thrombosis, and Vascular Biology.

Erectile dysfunction (ED) is an independent predictor of cardiovascular disease (CVD), according to a research letter published June 11 in Circulation.

The first coagulation monitoring device with built-in Bluetooth technology is expected to be commercially available this summer to warfarin patients in the United States, according to device-maker Roche Diagnostics.

Minorities, specifically blacks and Hispanics, are more than twice as likely to have a second intracerebral hemorrhage than white counterparts, according to a new study published in Neurology on June 6.

A research team at Worcester Polytechnic Institute in Massachusetts is engineering functioning human blood vessels which can mimic common cardiac and vascular problems, a tool they hope can be used to test new medications more quickly.

Almost 3 percent of infants and children hospitalized for pediatric arterial ischemic stroke (AIS) die in the hospital, according to a new international study published in the May 2018 edition of Pediatrics.